Lisen’s invention patent "MODEL, DIAGNOSTIC METHOD, AND APPLICATION THEREOF" about imprinted gene tumor early diagnosis technology was authorized by the European Patent Office on June 22, 2023. Patent number is EP:3633045. The Patent is registered in 17 countries in the Unitary Patent Protection Division, including Germany, France, Italy, Austria, Belgium, Bulgaria, Denmark, Estonia, Finland, Lithuania, Luxembourg, Latvia, Malta, the Netherlands, Portugal, Sweden and Slovenia. The patent is also valid in the UK and Spain. Relying on this patent and the subsequent layout of a series of patent applications, Lisen Imprinting will accelerate the research and development of Lisen Imprinting epigenetics, actively explore the European market, lead the global epigenetics research, promote the global application of imprinting gene tumor early diagnosis technology, and strive to create greater value for society.